Second-line antiretroviral therapy regimen change among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study
- PMID: 31307513
- PMCID: PMC6632209
- DOI: 10.1186/s13104-019-4429-3
Second-line antiretroviral therapy regimen change among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study
Abstract
Objective: This study was conducted to determine the rate of initial second-line ART regimen change and its predictors among adults living with HIV in Amhara region. A retrospective follow-up study was conducted between February, 2008 and April, 2016 at eight governmental hospitals of Amhara region. Person-times and Cox proportional hazard model were fitted to determine the rate and to identify the significant predictors of second-line treatment regimen change.
Results: A total of 897 records of patients were analyzed. The overall rate of initial second-line drug regimen change was 24.2 per 100 person years. The rate of regimen change was decreased for patients with formal education (HR: 0.77, 95% CI 0.61-0.97), under WHO clinical stage-III (HR: 0.57, 95% CI 0.45-0.73), and WHO clinical stage-IV (HR: 0.64, 95% CI 0.43-0.96). Patients who were taking CPT (HR: 2.05, 95% CI 1.45-2.89) had an increased rate of regimen change. Furthermore, the rate of regimen change was decreased for patients who were switched to second-line treatment due to virological failure (HR: 0.36, 95% CI 0.25-0.53), and due to drug toxicity (HR: 0.48, 95% CI 0.28-0.81). Therefore, addressing significant predictors to maximize the durability on the initial regimen among ART clients is essential.
Keywords: Amhara region; Regimen change; Retrospective study; Second-line.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Incidence and predictors of second-line antiretroviral treatment failure among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study.BMC Infect Dis. 2019 Jul 9;19(1):599. doi: 10.1186/s12879-019-4243-5. BMC Infect Dis. 2019. PMID: 31288748 Free PMC article.
-
Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study.BMC Infect Dis. 2020 Jul 1;20(1):460. doi: 10.1186/s12879-020-05177-2. BMC Infect Dis. 2020. PMID: 32611405 Free PMC article.
-
Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study.AIDS Res Ther. 2016 Feb 17;13:10. doi: 10.1186/s12981-016-0095-x. eCollection 2016. AIDS Res Ther. 2016. PMID: 26889204 Free PMC article.
-
Incidence and determinants of mortality among adult HIV infected patients on second-line antiretroviral treatment in Amhara region, Ethiopia: a retrospective follow up study.Pan Afr Med J. 2019 Jun 6;33:89. doi: 10.11604/pamj.2019.33.89.16626. eCollection 2019. Pan Afr Med J. 2019. PMID: 31489067 Free PMC article.
-
Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.Glob Health Action. 2016 Jan 12;9:29943. doi: 10.3402/gha.v9.29943. eCollection 2016. Glob Health Action. 2016. PMID: 26765104 Free PMC article.
Cited by
-
Effectors of Hyperlipidemia among HIV/AIDS patients with second-line antiretroviral therapy based on register data.Curr HIV Res. 2022 Aug 5;20(5):373-9. doi: 10.2174/1570162X20666220805103411. Online ahead of print. Curr HIV Res. 2022. PMID: 35929632 Free PMC article.
-
Determinants of Virologic Failure Among Adults on Second Line Antiretroviral Therapy in Wollo, Amhara Regional State, Northeast Ethiopia.HIV AIDS (Auckl). 2020 Nov 10;12:697-706. doi: 10.2147/HIV.S278603. eCollection 2020. HIV AIDS (Auckl). 2020. PMID: 33204171 Free PMC article.
-
Mortality Risk Factors Among People Living with HIV Receiving Second-line Antiretroviral Therapy in Rural China.Curr HIV Res. 2024;22(2):100-108. doi: 10.2174/011570162X280721240108065502. Curr HIV Res. 2024. PMID: 38310467
-
Effects of Chinese Medicine on the Survival of AIDS Patients Administered Second-Line ART in Rural Areas of China: A Retrospective Cohort Study Based on Real-World Data.Evid Based Complement Alternat Med. 2022 Jan 27;2022:5103768. doi: 10.1155/2022/5103768. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35126600 Free PMC article.
-
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.BMC Infect Dis. 2024 Mar 14;24(1):316. doi: 10.1186/s12879-024-09156-9. BMC Infect Dis. 2024. PMID: 38486188 Free PMC article.
References
-
- World Health Organisation . Antiretroviral therapy (ART) coverage among all age groups. Geneva: WHO; 2017.
-
- Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Hay SI, Mills EJ, Trickey A, Msemburi W, Coates MM. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016;3(8):e361–e387. doi: 10.1016/S2352-3018(16)30087-X. - DOI - PMC - PubMed
-
- Ethiopian public health institute . HIV related estimates and projections for Ethiopia. Addis Ababa: Ethiopian public health institute; 2017.
-
- World Health Organisation . Antiretroviral medicines in low-and middle-income countries: forecasts of global and regional demand for 2014–2018. Geneva: WHO; 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous